科学｜着床前検査の申請が増加中 / Science | Increase in Applications for Preimplantation Genetic Testing

Summary

The technique known as “preimplantation genetic testing (PGT-M)” is gaining attention as a way to prevent serious hereditary diseases from being passed on to children by examining the genes of embryos.

Since the review standards were relaxed in 2022, the number of applications has increased. Additionally, by expanding the focus to include older couples facing infertility, more couples are now able to utilize this testing. For families at risk of hereditary cancers, this technology will also become an important option.

Dialogue

This dialogue is fictional and based on the article.

Chako: Hey Log, do you know about preimplantation genetic testing? It seems to be increasing in popularity lately!
Log: Oh, I’ve heard of it. It’s the test that examines the genes of fertilized eggs to prevent hereditary diseases, right?
Chako: Exactly! They’ve relaxed the criteria, so more people can get it now!
Log: It’s great news, especially since they’ve added advanced maternal age infertility to the list. That’s particularly good for older parents.
Navi: Preimplantation genetic testing is considered an important technology for reducing the risk of hereditary diseases. It really expands the options available.
Chako: It sounds like a good thing for the children of the future!

Admin’s Note

In this article, I gained a clear understanding of the background behind the increasing number of applications for preimplantation genetic testing. It is particularly noteworthy that the relaxation of criteria has allowed more couples to take advantage of this option. Considering the inclusion of provisions for older infertility patients, it is expected that this technology will become more widely adopted by families in the future. Expanding the options for preventing hereditary diseases will also be a significant benefit for society as a whole.